Gamco Investors INC. ET AL Reduces Position in Danaher Co. (NYSE:DHR)

Gamco Investors INC. ET AL lessened its position in shares of Danaher Co. (NYSE:DHRFree Report) by 22.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,653 shares of the conglomerate’s stock after selling 3,977 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Danaher were worth $3,387,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. DHJJ Financial Advisors Ltd. bought a new position in shares of Danaher during the 3rd quarter worth approximately $25,000. IAG Wealth Partners LLC increased its stake in Danaher by 344.8% during the 2nd quarter. IAG Wealth Partners LLC now owns 129 shares of the conglomerate’s stock valued at $31,000 after purchasing an additional 100 shares in the last quarter. OFI Invest Asset Management acquired a new position in Danaher during the 3rd quarter valued at approximately $30,000. First Capital Advisors Group LLC. acquired a new position in Danaher during the 2nd quarter valued at approximately $32,000. Finally, WFA of San Diego LLC acquired a new position in Danaher during the 2nd quarter valued at approximately $32,000. Institutional investors own 76.71% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on DHR shares. TheStreet upgraded shares of Danaher from a “c+” rating to a “b-” rating in a research note on Friday, December 8th. Citigroup upped their price target on shares of Danaher from $255.00 to $280.00 and gave the company a “buy” rating in a research note on Wednesday, January 31st. Barclays lowered shares of Danaher from an “overweight” rating to an “equal weight” rating and set a $240.00 price target on the stock. in a research note on Wednesday, January 24th. HSBC began coverage on shares of Danaher in a research note on Monday, December 18th. They issued a “hold” rating on the stock. Finally, Raymond James increased their price objective on shares of Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $266.00.

Read Our Latest Stock Analysis on Danaher

Danaher Stock Performance

Shares of NYSE DHR opened at $245.88 on Friday. The company’s fifty day moving average price is $230.82 and its 200 day moving average price is $232.04. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $249.89. The company has a market capitalization of $181.69 billion, a PE ratio of 38.48, a price-to-earnings-growth ratio of 3.72 and a beta of 0.85. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.18. The business had revenue of $6.41 billion for the quarter, compared to the consensus estimate of $6.10 billion. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The company’s revenue was down 10.2% compared to the same quarter last year. During the same period last year, the firm posted $2.87 earnings per share. On average, research analysts predict that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Friday, December 29th were issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.39%. The ex-dividend date of this dividend was Thursday, December 28th. Danaher’s payout ratio is 15.02%.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total transaction of $816,724.48. Following the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at $4,898,360.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.